Skip to main content
. 2024 Sep 12;14:372. doi: 10.1038/s41398-024-03059-8

Fig. 2. Dosing day assessments for the effects of midazolam.

Fig. 2

A Performance on the California Verbal Learning Test (CVLT) administered 15 min after the initial midazolam bolus, as a function of midazolam (Midaz) target serum concentration. Each symbol represents one participant. Score range for the CVLT is 0 to 16. B Observer’s Assessment of Arousal and Sedation (OAA/S) scores averaged over the dosing session as a function of midazolam target serum concentration. Each symbol is the OAA/S score for one participant averaged across the assessment times during the dosing session. Error bars represent standard deviation. The two participants who exhibited memory impairment in Fig. 4 are indicated by filled symbols.